Sophia Genetics, fresh off IPO, to triple Boston office space by end of year

Two months after its $234 million IPO, genomics testing firm Sophia Genetics (Nasdaq: SOPH) is planning to triple the size of its Copley Square offices, co-founder and CEO Jurgi Camblong told the Business Journal on Thursday.